Panacea Joins HighLight Capital et al in Antibody-based Therapies
02 Jan 2025
US$ 19.00
US-based Panacea Venture and Shanghai Healthcare Capital have co-led the near US$50 million pre-series A financing ......
Related Publications
Granite Asia has appointed Ms Ming Eng as a partner, responsible for co-managing its credit solution offerings ......
Qiming Venture Partners (Qiming) has agreed to acquire a 26.1% stake in the Shenzhen-listed Zhengzhou Tiamaes ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.